Abstract | BACKGROUND:
Ischemic stroke is one of the main causes of death and disability worldwide. It is caused by the cessation of cerebral blood flow resulting in the insufficient delivery of glucose and oxygen to the neural tissue. The inflammatory response initiated by ischemic stroke in order to restore tissue homeostasis in the acute phase of stroke contributes to delayed brain damage. METHODS: RESULTS: CONCLUSIONS: Our results suggest that SSO is an anti-inflammatory and a possible therapeutic candidate in diseases such as stroke where inflammation is a central hallmark.
|
Authors | Hiramani Dhungana, Mikko T Huuskonen, Merja Jaronen, Sighild Lemarchant, Humair Ali, Velta Keksa-Goldsteine, Gundars Goldsteins, Katja M Kanninen, Jari Koistinaho, Tarja Malm |
Journal | Journal of neuroinflammation
(J Neuroinflammation)
Vol. 14
Issue 1
Pg. 237
(Dec 04 2017)
ISSN: 1742-2094 [Electronic] England |
PMID | 29202856
(Publication Type: Journal Article)
|
Chemical References |
- Neuroprotective Agents
- Oleic Acids
|
Topics |
- Animals
- Cells, Cultured
- Inflammation
(etiology, pathology)
- Mice
- Neuroprotective Agents
(pharmacology)
- Oleic Acids
(pharmacology)
- Stroke
(complications, pathology)
|